Merck begins late-stage trial of experimental Covid-19 drug

Reuters

01 September, 2021, 05:00 pm

Last modified: 01 September, 2021, 05:03 pm

Merck begins late-stage trial of experimental Covid-19 drug

Reuters

01 September, 2021, 05:00 pm

Last modified: 01 September, 2021, 05:03 pm

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

Merck & Co Inc and partner Ridgeback Biotherapeutics said on Wednesday they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of Covid-19 infection.

Keep updated, follow The Business Standard's Google news channel

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Unlike other halls, the International Hall exclusively houses foreign students. Photos: Junayet Rashel

The ‘national’ interest in DU’s ‘international’ hall

10h | Panorama

Photo: Microsoft

Windows 365 Link: A new era for cloud computing?

9h | Tech

Photo: Le Reve

Winter escapes and stylish layers

15h | Mode

Photo: Collected

From dance hall to hotel to hospital: The story of Hotel Shahbagh

20h | Features

Met office forecasts rain likely over parts of country

Met office forecasts rain likely over parts of country

11h | Videos

How the bullet train transformed Japan

How the bullet train transformed Japan

11h | Videos

Should the Fab Five have their jersey numbers retired?

Should the Fab Five have their jersey numbers retired?

1d | Videos

West Bengal government removes obstacles in potato and onion exports

West Bengal government removes obstacles in potato and onion exports

1d | Videos